Predictive Oncology (POAI) - 2025 Q4 - Annual Report

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________________ to _________________________ Commission file number: 001-36790 Axe Compute Inc. (Exact name of registrant as specified in its charter) Delaware 33-1007393 (State or other jurisdiction of (I.R.S. Employer incorporation or organizat ...

Predictive Oncology (POAI) - 2025 Q4 - Annual Report - Reportify